These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1082668)

  • 1. Adaptation to tissue culture of the murine leukemia ASL1, a high producer of TL (thymus leukemia) antigen.
    Williams JL; Stanton TH; Wolcott RM
    Tissue Antigens; 1975 Nov; 6(5):335-41. PubMed ID: 1082668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of cytotoxic T lymphocytes in the EL4 mouse leukemia system: increased activity of immune spleen and peritoneal cells following preincubation and cell fractionation procedures.
    Vasudevan DM; Brunner KT; Cerottini JC
    Int J Cancer; 1974 Sep; 14(3):301-13. PubMed ID: 4549212
    [No Abstract]   [Full Text] [Related]  

  • 3. Murine leukemia cell hybrids: the quantity of TL antigens expressed by parental and hybrid cells fails to correlate with their sensitivity to TL antibody and complement.
    Cohen EP; Liang W
    J Supramol Struct; 1978; 9(4):525-36. PubMed ID: 750764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by sera and soluble antigens of T-cell-mediated cytotoxicity against leukaemia-associated antigens.
    Ting CC; Rogers MJ
    Nature; 1977 Apr; 266(5604):727-9. PubMed ID: 301609
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of specific cellular immunity toward murine leukemia in mice rejecting syngeneic somatic hybrid cells.
    Liang W; Cohen EP
    J Immunol; 1977 Sep; 119(3):1054-60. PubMed ID: 302270
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular immunoadsorbents. An improved technique for specific depletion of cytotoxic (T) lymphoid cells.
    Kedar E; Ortiz de Landazuri M; Bonavida B; Fahey JL
    J Immunol Methods; 1974 May; 5(1):97-102. PubMed ID: 4546233
    [No Abstract]   [Full Text] [Related]  

  • 7. Antigenic modulation in vitro. III. Failure to modulate H-2 antigens on several mouse tumors.
    Richards JM; Jacobson JB; Stackpole CW
    J Natl Cancer Inst; 1979 Apr; 62(4):825-32. PubMed ID: 311870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and processing of molecules bearing thymus leukemia antigen.
    Rothenberg E; Boyse EA
    J Exp Med; 1979 Oct; 150(4):777-91. PubMed ID: 315985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the mechanisms for the induction of in vivo tumor immunity. II. Distribution and homing of cytotoxic effector and precursor cells.
    Ting CC
    J Natl Cancer Inst; 1978 Feb; 60(2):437-44. PubMed ID: 304488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-leukocyte serum: suppression of antibody-forming cells and their precursors in vivo and in vitro.
    Allen J; Friedman H; Mills L
    Transplant Proc; 1969 Mar; 1(1):436-8. PubMed ID: 4944256
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosette forming cells in the spleens of mice with lymphoid and myeloid leukemia.
    Gabrilovac J; Boranić M
    Exp Hematol; 1977 Jan; 5(1):13-8. PubMed ID: 319009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional properties of T and B lymphocytes in cell-mediated immunity.
    Petrányl GG
    Haematologia (Budap); 1974; 8(1-4):361-82. PubMed ID: 4142621
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo modulation of thymus-leukemia antigens on mouse leukemia cells and thymocytes: retention of modulating antibody on the cell surface.
    Jacobson JB; Galuska S; Stackpole CW
    J Natl Cancer Inst; 1978 Sep; 61(3):819-25. PubMed ID: 80455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro recognition of alloantigens: nature of responding and stimulating cells.
    Berman M; Puryear K; Argyris BF
    Cell Immunol; 1976 Apr; 23(1):126-39. PubMed ID: 131649
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of thymus-leukemia antigens on mouse leukemia cells induced by IgG, but not IgM, antibody.
    Stackpole CW
    J Natl Cancer Inst; 1980 Apr; 64(4):917-23. PubMed ID: 6929003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat.
    Tucker DF; Dennert G; Lennox ES
    J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunity in leukemia.
    Gatti RA
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:275-81. PubMed ID: 4277522
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular and humoral immunity to leukemia cells in BCG-induced growth control of a murine leukemia.
    Olsson L; Florentin I; Kiger N; Mathé G
    J Natl Cancer Inst; 1977 Oct; 59(4):1297-306. PubMed ID: 904001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement sensitivity of somatic hybrids of a complement-resistant murine leukemia cell line.
    Liang W; Cohen EP
    J Natl Cancer Inst; 1975 Aug; 55(2):309-17. PubMed ID: 51086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.